SPDR S&P Biotech
(PCQ: XBI)
104.73
-1.39
-1.31%
-1.39
-1.31%
MORE ON XBI
DETAILS
| Symbol | Value ($) |
|---|---|
| Previous Close | 106.12 |
| Open | 106.65 |
| Day's High | 106.96 |
| Day's Low | 104.66 |
| Volume | 365,328 |
| Bid | 104.32 |
| Bid Size | 500 |
| Ask | 105.17 |
| Ask Size | 500 |
| 52-Wk High | 113.53 |
| 52-Wk Low | 81.35 |
| Beta | 1.00 |
| YTD NAV Return | +19.05 |
| YTD Market Return | +19.19 |
| Inception Date | 1/31/2006 |
| Shares Outstanding | 7.30 Mil |
- Last trade 6/19/2013 4:00 PM ET
INVESTMENT OBJECTIVE
| NA |
|---|
| The investment seeks to provide investment results that, before fees and expenses, correspond to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. The fund employs a replication strategy in seeking to track the performance of the S&P Biotechnology Select Industry Index. It generally invests substantially all, but at least 80%, of total assets in the securities comprising the index. The fund may invest in equity securities that are not included in the index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. It is non-diversified. |
PERFORMANCE
| Symbol | Value ($) |
|---|---|
| 1 Month | -4.74% |
| 3 Months | 6.52% |
| 1 Year | 23.20% |
| 3 Years* | 23.53% |
| 5 Years* | 12.52% |
- * Annualized returns
- Data through 6/19/2013 12:00 AM ET
VIDEO ON MSN MONEY
TOP NEWS
-
InvestorPlace | 5/31/2013
-
InvestorPlace | 5/17/2013
-
InvestorPlace | 4/26/2013
-
Seeking Alpha | 4/22/2013
-
InvestorPlace | 4/22/2013
Morningstar Ratings
| Symbol | Value ($) |
|---|---|
| Category | Health |
| Morningstar Risk | High |
| Morningstar Rating | |
| Morningstar Return | Average |
HOLDINGS
| Symbol | Value ($) |
|---|---|
| Stocks | 99.91% |
| Cash | 0.09% |
| Fixed Income | 0.00% |
| Other | 0.00% |
TOP 10 HOLDINGS
| NAME | % NET ASSETS |
|---|---|
| NPS Pharmaceuticals Inc | 4.04% |
| Aegerion Pharmaceuticals, Inc. | 3.73% |
| Vertex Pharmaceuticals | 3.23% |
| Theravance, Inc. | 3.11% |
| Regeneron Pharmaceuticals, Inc. | 3.04% |
| Alkermes PLC | 2.83% |
| Isis Pharmaceuticals | 2.82% |
| Sarepta Therapeutics Inc | 2.71% |
| Biogen Idec Inc | 2.64% |
| Gilead Sciences Inc | 2.48% |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
XBI BUZZ
MARKET UPDATE
[BRIEFING.COM] Equities ended on their lows with the S&P 500 down 1.4%. The S&P entered today's session with a week-to-date gain of 1.5% as investors expected reassuring words from today's Federal Open Market Committee Statement. Stocks traded with s
...
More
MORE MARKET NEWS
Sponsored by:
INVESTING TIPS AND TOOLS